Recent News
Chronic Inflammatory Bowel Diseases: Does Evolutionary Medicine Offer New Therapeutic Approaches?
Joint press release by the Max Planck Institute for Evolutionary Biology and the Cluster of Excellence PMI – Precision Medicine for Chronic Inflammatory Diseases of the Faculty of Medicine at Kiel University read more
Andre Franke Visits Shanghai and Beijing to Strengthen International Research Collaborations
From November 12 to November 20, 2024, Andre Franke visited Shanghai and Beijing. During his visit, he met with key collaborators and delivered two talks, presenting the Institute’s recent advances in high-throughput immunogenetics and microbiome …read more
10th International Human Microbiome Consortium (IHMC) Congress 2024
Together with Nadia Andrea Andreani and another colleague from my institute, we attended the 10th International Human Microbiome Consortium (IHMC) Congress 2024, held in the historic city of Rome from June 22-25, 2024. Launched in …read more
International Symposium on Immunometabolism in Chronic Inflammation
12.09.2024 – 13.09.2024 | Wissenschaftszentrum Kiel
Scientific conference “Immunometabolism in chronic inflammation”
12 & 13 September 2024, Wissenschaftszentrum Kiel, Frauenhoferstraße 13, 24118 Kiel
Jan Henrik Ardenjaer-Larsen – Denmark
Lucio Frydman – Israel
Samuel Huber – Germany
Hernriette …read more
PhD position available in subproject P1 (PI Andre Franke)
The Immunogenetics and Bioinformatics group of Prof. Andre Franke at the Institute of Clinical Molecular Biology (IKMB), Kiel University, offers a PhD position limited for 4 years. The preferred starting date is July 1, 2024.
The position focuses …read more
6.1 million euros for “miTarget” – DFG extends funding for another 4 years
Following a positive on-site review in December 2023, the DFG finally announced its decision on March 25, 2024: miTarget will be funded for another four years with a total of almost 6.1 million euros.
